PAHC - CIK 0001069899
The table below shows PHIBRO ANIMAL HEALTH CORP's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $9.30M | $12.62M | $16.20M | -$10.70M | $3.82M | $1.70M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$21.01M | -$2.93M | -$15.35M | -$16.15M | -$20.67M | -$13.63M |
| Dividends paid | $4.86M | $4.86M | $4.86M | $4.86M | $4.86M |
PHIBRO ANIMAL HEALTH CORP reported operating cash flow of $80.12M for fiscal year 2025. That is down 8.5% from $87.59M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $37.22M (FY 2016) to $80.12M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $4.85M |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $16.34M | -$29.20M | $1.30M | $29.32M | $8.27M | $6.46M |